Applied Historical Cash Flow
| APDN Stock | USD 0.15 0.01 6.25% |
Analysis of Applied DNA cash flow over time is an excellent tool to project Applied DNA Sciences future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Capital Expenditures of 85.7 K or Total Cash From Financing Activities of 1 M as it is a great indicator of Applied DNA ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Applied DNA Sciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Applied DNA Sciences is a good buy for the upcoming year.
Applied |
About Applied Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Applied balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Applied's non-liquid assets can be easily converted into cash.
Applied DNA Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from Applied DNA's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Applied DNA Sciences current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied DNA Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. At this time, Applied DNA's Change Receivables is very stable compared to the past year. As of the 29th of November 2024, Cash And Cash Equivalents Changes is likely to grow to about 6.8 M, while Capital Expenditures is likely to drop about 85.7 K.
| 2021 | 2022 | 2023 | 2024 (projected) | Begin Period Cash Flow | 6.6M | 15.2M | 17.5M | 18.4M | End Period Cash Flow | 15.2M | 7.9M | 9.1M | 9.5M |
Applied DNA cash flow statement Correlations
Click cells to compare fundamentals
Applied DNA Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Applied DNA cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Working Capital | 527.7K | (3.6M) | 954.6K | 2.4M | 2.2M | 2.3M | |
| Capital Expenditures | 1.1M | 2.5M | 489.6K | 78.4K | 90.2K | 85.7K | |
| Net Income | (13.0M) | (14.3M) | (8.3M) | (9.9M) | (9.0M) | (9.4M) | |
| Free Cash Flow | (12.2M) | (15.9M) | (9.5M) | (6.3M) | (5.7M) | (5.9M) | |
| Other Cashflows From Financing Activities | 8.1M | 2.6M | 3.8M | (1.1M) | (1.3M) | (1.2M) | |
| Total Cash From Operating Activities | (11.1M) | (13.4M) | (9.0M) | (6.2M) | (5.6M) | (5.9M) | |
| Total Cash From Financing Activities | 19.4M | 14.7M | 18.1M | 952.5K | 1.1M | 1.0M | |
| Other Non Cash Items | 26.0K | 2.0M | (5.5M) | (1.1M) | (1.0M) | (951.9K) | |
| Change In Cash | 7.2M | (1.2M) | 8.7M | (7.3M) | (8.4M) | (8.0M) | |
| End Period Cash Flow | 7.8M | 6.6M | 15.2M | 7.9M | 9.1M | 9.5M | |
| Begin Period Cash Flow | 559.0K | 7.8M | 6.6M | 15.2M | 17.5M | 18.4M | |
| Depreciation | 285.7K | 844.4K | 1.3M | 1.4M | 1.2M | 1.0M | |
| Change To Inventory | (354.7K) | (872.6K) | 767.7K | 272.2K | 313.1K | 328.7K | |
| Change To Account Receivables | 600.4K | (2.6M) | (533.0K) | 3.1M | 3.5M | 3.7M | |
| Stock Based Compensation | 1.0M | 1.7M | 2.5M | 1.0M | 1.2M | 1.9M | |
| Sale Purchase Of Stock | 4.2M | 3.9M | 18.7M | 952.5K | 1.1M | 1.0M | |
| Total Cashflows From Investing Activities | (67.4K) | (1.1M) | (2.5M) | (489.6K) | (440.6K) | (462.6K) | |
| Change To Netincome | 2.6M | 1.0M | 3.7M | (3.0M) | (2.7M) | (2.5M) | |
| Change To Liabilities | 667.9K | 427.4K | (135.3K) | 1.2M | 1.4M | 1.5M | |
| Change To Operating Activities | 23.8K | (27.3K) | 30.4K | (493.2K) | (443.9K) | (421.7K) | |
| Investments | (1.1M) | (2.5M) | (489.6K) | (1.1M) | (986.2K) | (1.0M) | |
| Issuance Of Capital Stock | 10.6M | 13.8M | 14.4M | 10.3M | 11.9M | 10.3M |
Pair Trading with Applied DNA
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Applied DNA position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Applied DNA will appreciate offsetting losses from the drop in the long position's value.Moving against Applied Stock
| 0.86 | GLW | Corning Incorporated | PairCorr |
| 0.86 | JBL | Jabil Circuit | PairCorr |
| 0.8 | ZBRA | Zebra Technologies | PairCorr |
| 0.73 | FLEX | Flex | PairCorr |
| 0.73 | MYNA | Mynaric AG ADR | PairCorr |
The ability to find closely correlated positions to Applied DNA could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Applied DNA when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Applied DNA - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Applied DNA Sciences to buy it.
The correlation of Applied DNA is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Applied DNA moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Applied DNA Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Applied DNA can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied DNA Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Electronic Equipment, Instruments & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Applied DNA. If investors know Applied will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Applied DNA listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (7.50) | Revenue Per Share 2.202 | Quarterly Revenue Growth (0.73) | Return On Assets (0.57) | Return On Equity (0.76) |
The market value of Applied DNA Sciences is measured differently than its book value, which is the value of Applied that is recorded on the company's balance sheet. Investors also form their own opinion of Applied DNA's value that differs from its market value or its book value, called intrinsic value, which is Applied DNA's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Applied DNA's market value can be influenced by many factors that don't directly affect Applied DNA's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Applied DNA's value and its price as these two are different measures arrived at by different means. Investors typically determine if Applied DNA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Applied DNA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.